Zhong Guo Jing Ji Wang·2025-06-01 08:02Core Viewpoint - The Beijing Stock Exchange has decided to terminate the review of Wufeng Chicheng Biotechnology Co., Ltd.'s public offering and listing application due to the company's withdrawal of its application [1][3]. Company Overview - Wufeng Chicheng Biotechnology Co., Ltd. specializes in the research, production, and sales of hydrolyzed tannin products derived from plants rich in tannins [3]. - The company was founded by Chen Chiqing and Mao Yefu, who are the controlling shareholders [4]. Shareholding Structure - Chen Chiqing directly holds 20.40% of the shares and indirectly controls an additional 1.78% through a partnership, totaling 22.18% [3]. - Mao Yefu directly holds 19.43% and indirectly controls 0.84%, totaling 20.27%. Together with his family members, he controls 25.41% of the shares [4]. - Combined, Chen Chiqing and Mao Yefu control 47.58% of the company [4]. Initial Public Offering Details - The company initially planned to issue up to 35.666 million shares, with a public shareholder ratio of at least 25% post-issue [4]. - The intended fundraising amount was 210 million yuan, allocated for the construction of the second phase of the company's industrial park and for working capital [5]. - The total investment for the industrial park project was estimated at 266.7142 million yuan, with 160 million yuan planned to be raised from the public offering [5].